These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8845585)

  • 1. Bisphosphonates and the treatment of bone disease in the elderly.
    Johansen A; Stone M; Rawlinson F
    Drugs Aging; 1996 Feb; 8(2):113-26. PubMed ID: 8845585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
    Fleisch H
    Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New bisphosphonates in the treatment of bone diseases.
    Gatti D; Adami S
    Drugs Aging; 1999 Oct; 15(4):285-96. PubMed ID: 10582775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates: from the laboratory to the clinic and back again.
    Russell RG; Rogers MJ
    Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates in bone diseases.
    Sparidans RW; Twiss IM; Talbot S
    Pharm World Sci; 1998 Oct; 20(5):206-13. PubMed ID: 9820883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology and therapeutic utility of bisphosphonates.
    Lourwood DL
    Pharmacotherapy; 1998; 18(4):779-89. PubMed ID: 9692651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Fitton A; McTavish D
    Drugs; 1991 Feb; 41(2):289-318. PubMed ID: 1709854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.
    Gennari C; Nuti R; Agnusdei D; Camporeale A; Martini G
    Drug Saf; 1994 Sep; 11(3):179-95. PubMed ID: 7811400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New bisphosphonates in osteoporosis.
    Fleisch H
    Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates: from grandparents to grandchildren.
    Srivastava T; Alon US
    Clin Pediatr (Phila); 1999 Dec; 38(12):687-702. PubMed ID: 10618761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in the therapeutic applications of bisphosphonates.
    Brown DL; Robbins R
    J Clin Pharmacol; 1999 Jul; 39(7):651-60. PubMed ID: 10392318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bisphosphonates: indications in bone diseases other than osteoporosis].
    Abdelmoula LC; Ben M'barek R; Ben Hadj Yahia C; Tekaya R; Testouri N; Chaabouni L; Zouari R
    Tunis Med; 2011 Jun; 89(6):511-6. PubMed ID: 21681711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases.
    Rosen CJ; Kessenich CR
    Drugs; 1996 Apr; 51(4):537-51. PubMed ID: 8706593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition.
    Drake MT; Cremers SC
    Mol Interv; 2010 Jun; 10(3):141-52. PubMed ID: 20539033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for the use of alendronate in osteoporosis.
    Kanis JA; Gertz BJ; Singer F; Ortolani S
    Osteoporos Int; 1995 Jan; 5(1):1-13. PubMed ID: 7703618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of bisphosphonates in involutional osteoporosis.
    Ott SM
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.